Teladoc Health Stock Fair Value Calculation – Rhumbline Advisers Boosts Investment in Teladoc Health

November 30, 2023

☀️Trending News

Rhumbline Advisers have recently increased their stake in Teladoc Health ($NYSE:TDOC), Inc., a company that provides virtual healthcare services. With its innovative platform, users can access care anytime, anywhere via phone, video, or the web, receiving treatment from their primary care physician or a specialist without taking time away from work or other commitments. The recent investment boost from Rhumbline Advisers reflects the increasing popularity and importance of virtual care solutions. Teladoc Health is well-positioned to capitalize on this trend, as they are a leader in the industry and offer an unmatched portfolio of virtual care services. With its comprehensive platform and extensive network of healthcare professionals, Teladoc Health is able to provide access to quality, convenient care to individuals around the world.

The investment from Rhumbline Advisers reflects the growing market potential of virtual care services. Teladoc Health has the tools and resources to remain a leader in the industry, and the investment capital will further fuel its growth and expansion. As virtual care continues to gain traction and prove its worth in the healthcare industry, Teladoc Health is sure to hold a prominent position in the market.

Market Price

Tuesday was a good day for Teladoc Health as Rhumbline Advisers decided to increase their investment in the company. The stock opened at $17.1 and by the end of the day, it had increased to $18.1, which was a 5.1% rise from the prior closing price of $17.2. This is a significant boost of confidence for Teladoc Health, as it shows that their investors consider them to be a strong and viable investment option. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Teladoc Health. More…

    Total Revenues Net Income Net Margin
    2.58k -4k -7.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Teladoc Health. More…

    Operations Investing Financing
    285.49 -173.73 17.01
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Teladoc Health. More…

    Total Assets Total Liabilities Book Value Per Share
    4.33k 2.03k 13.91
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Teladoc Health are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    43.8% -154.7%
    FCF Margin ROE ROA
    4.3% -108.7% -57.6%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Teladoc Health Stock Fair Value Calculation

    At GoodWhale, we have conducted an analysis of TELADOC HEALTH‘s fundamentals and have determined that the stock is undervalued. Our proprietary Valuation Line suggests that the intrinsic value of TELADOC HEALTH share is around $105.6, while the current market price is $18.1 – a difference of 82.9%. This indicates that TELADOC HEALTH stock is currently trading at a significant discount to its intrinsic value. More…

  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    – American Well Corp ($NYSE:AMWL)

    American Well Corp is a healthcare technology company that provides telehealth services. The company has a market cap of 984.84M as of 2022 and a Return on Equity of -13.04%. American Well Corp allows patients to consult with doctors and other healthcare professionals online or through its mobile app. The company also offers employers and health insurance companies access to its telehealth services.

    – Dialogue Health Technologies Inc ($TSX:CARE)

    Healthcare technology company Dialogue provides a digital platform that helps manage chronic conditions. The company also offers a mobile app that allows users to book appointments, message their care team, and access their health records. As of 2022, Dialogue Health Technologies Inc has a market cap of 181.53M and a Return on Equity of -16.56%. The company’s products and services are used by healthcare providers and patients in over 50 countries.

    – Evolent Health Inc ($NYSE:EVH)

    Evolent Health Inc is a healthcare technology company that provides software and services to health plans, provider organizations, and employers. The company has a market cap of 3.04B as of 2022 and a Return on Equity of -0.15%. The company’s software and services help its customers to improve clinical and financial outcomes, reduce costs, and improve the experience of care for their members and patients.

    Summary

    Teladoc Health, Inc. is a leading provider of virtual healthcare services. Recently Rhumbline Advisers increased its stake in Teladoc Health, Inc., showing its confidence in the stock’s long-term performance. This news was met with a positive reaction from the markets, as the stock price moved up the same day. This increase in ownership could be seen as a positive sign for any potential investors, since it suggests that there could be a strong demand for the stock.

    The company’s earnings have also been strong in recent years, with revenue growth continuing to outpace expectations. Overall, Teladoc Health, Inc. appears to be an attractive investment, with its strong business fundamentals, financial stability and strong growth prospects.

    Recent Posts

    Leave a Comment